Vascular smooth muscle growth and extracellular matrix deposition: Is there a role for the sympathetic nervous system?

Journal of Hypertension

Volumn 20, Issue 2, 2002, Pages 179-181

  Schiffrin, Ernesto L ^a  

^a NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADRENERGIC SYSTEM; ALPHA ADRENERGIC RECEPTOR BLOCKING; ALPHA ADRENERGIC STIMULATION; BETA ADRENERGIC RECEPTOR BLOCKING; CELL GROWTH; CLINICAL TRIAL; DRUG EFFECT; EXTRACELLULAR MATRIX; HUMAN; HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

EID: 0036464209     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200202000-00005     Document Type: Short Survey

References (22)

1. Combined effect of neonatal sympathectomy and adrenal demedullation on blood pressure and vascular changes in spontaneously hypertensive rats
2. The effect of neonatal treatment of rats with nerve growth factor on the blood pressure and structure of the mesenteric arteries
3. Alpha 1-adrenergic stimulation and beta 2-adrenergic inhibition of DNA synthesis in vascular smooth muscle cells
4. Chronic alpha 1-adrenoreceptor stimulation increases DNA synthesis in rat arterial wall. Modulation of responsiveness after vascular injury
5. Circulating catecholamine levels in human and experimental hypertension
6. Elevated sympathetic nerve activity in borderline hypertensive humans: Evidence from direct intraneural recordings
7. Sympathetic activation in the pathogenesis of hypertension and progression of organ damage
8. The regulation of human vascular smooth muscle extracellular matrix protein production by α and β adrenoceptor stimulation
9. Hypertension, small arteries, and pathways for angiotensin II generation - 'The proper study of mankind is man'
10. 2 receptors in the development and maintenance of DOCA-salt hypertension
11. Effects of a beta blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension
12. Progressive improvement in the structure of resistance arteries of hypertensive patients after 2 years of treatment with an angiotensin converting enzyme inhibitor. Comparison with effects of a beta-blocker
13. Comparison of effects of angiotensin converting enzyme inhibition and beta blockade on function of small arteries from hypertensive patients
14. Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension
15. Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin antagonist losartan
16. 1 receptor antagonist losartan in essential hypertension
17. Effect of crossing over hypertensive patients from a beta-blocker to an angiotensin receptor antagonist on resistance artery structure and on endothelial function
18. Structure and mechanical properties of resistance arteries in hypertension
19. Cardiovascular protection and blood pressure reduction: A meta-analysis
20. Are β-blockers efficacious as first-line therapy for hypertension in the elderly?
21. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)
22. Norepinephrine-induced aortic hyperplasia and extracellular matrix deposition are endothelin-dependent